期刊文献+

核仁组成区嗜银蛋白及Ki-67在乳腺癌前驱病变中的意义 被引量:9

Significance of AgNOR analysis and the expression of Ki-67 in the precursor lesions of the breast carcinoma
原文传递
导出
摘要 目的探讨核仁组成区嗜银蛋白(AgNOR)及细胞增殖指数(PIki-67)在乳腺癌前驱病变中的意义。方法将76例乳腺癌前驱病变,包括导管上皮不典型增生(ADH)25例、低度导管原位癌(DCIS)17例、中度导管原位癌14例及高度导管原位癌20例,制成组织芯片,进行AgNOR嗜银染色及Ki-67免疫组织化学染色,图像定量分析AgNOR染色结果并计算PI Ki-67结果AgNOR颗粒形态、大小在各病变中存在差异;每个细胞AgNOR颗粒平均个数、AsNOn颗粒总面积、单个Ag—NOR颗粒面积、PIKi埘从ADH到高度DCIS逐渐增高,ADH、低度DCIS与高度DCIS的差异均有统计学意义(P〈0.01),ADH与低度DCIS在每个细胞AgNOR颗粒平均个数上的差异有统计学意义(P〈0.05)。结论AgNOR与Ki-67是乳腺癌前驱病变诊断及鉴别诊断的指标之一。 Objective To study the diagnostic and differential diagnostic significance of argyro- philic nucleolar organizer region (AgNOR) and cellular proliferation index ( PIKi-67 ) in the precursor lesions of the breast carcinoma. Methods Image quantitative analysis of AgNOR and immunostains of Ki-67 in tissue microarray sections from 76 biopsies of the precursor lesions of the breast carcinoma. Results There were some differences in granulae sizes and shapes of AgNOR among the precursor lesions of the breast carcinoma. The number of AgNORs per nucleu, total area of AgNORs,mean area of a single AgNOR, PIki-67 were increasing from ADH to high-grade DCIS, and there was statistical difference between ADH, low-grade DCIS,respectively and high-grade DCIS. The number of AgNORs per nucleu was statistically different be- tween ADH and low-grade DCIS. Conclusion AgNOR and Ki-67 could be regarded as assistant indicators in the diagnosis and differential diagnosis of the precursor lesions of the breast carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第9期1462-1463,共2页 Chinese Journal of Experimental Surgery
关键词 乳腺肿瘤 不典型增生 导管原位癌 核仁组成区嗜银蛋白 KI-67 组织 芯片 Breast neoplasia Atypical ductal hyperplasia Ductal carcinoma in situ Argyrophilic nucleolar organizer regions Ki-67 Tissue microarray
  • 相关文献

参考文献2

二级参考文献16

  • 1张鸽文,汤恢焕,王志明.Survivin和血管内皮生长因子在肝细胞癌中的表达及其与肿瘤血管生成的关系[J].中华实验外科杂志,2005,22(5):626-626. 被引量:5
  • 2Morinaga S, Nakamura Y, Ishiwa N, et al. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.Oncol Rep, 2004, 12 : 1189-1194.
  • 3Miyachi K, Sasaki K, Onodera S, et al. Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer, 2003, 6:217-224.
  • 4Ikeguchi M, Kaibara N. Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Br J Cancer, 2002, 87:883 -887.
  • 5Yu J, Leung WK, Ebert MP, et al. Increased expression of survivin in gastric cancer patients end in first degree relatives. Br J Cancer, 2002,87:91-97.
  • 6ALtieri DC, Marchisioc. Survivin apoptosis an interloper between cell death and cell proliferation in caner. Lab Invest, 1999, 79:1327-1333.
  • 7Ito T, shiraki K, Sugimoto K, et al. Survivin promotes cell proliferation in humam hepatocellular Careionma. Hepatolloy, 2000, 31 : 1081-1085.
  • 8Takai N, Miyazaki T, Nishida M, et al. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Letters, 2002, 184 : 105-116.
  • 9Kim PJ, Plescia J, Clevers H, et al. Survivin and molecular pathogenesis of colorectal cancer. Lancet, 2003, 362: 205-209.
  • 10Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer Anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol, 1998, 152:43-49.

共引文献23

同被引文献90

引证文献9

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部